The Board inter alia considered and approved the following business transactions: 1) Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Ltd announced two board changes effective June 20, 2025: Mr. Naveenakumar Kunjaru stepped down as Chairman but continues as Managing Director, while Dr. Lalitkumar Anande, already a Non-Executive Independent Director, was elevated to the role of Chairman. This separates the Chairman and MD roles, aligning with better corporate governance practices. Separately, the company announced a foray into the diagnostic testing, home sample collection, and tele-consultation segment, to be delivered through a dedicated website and mobile app. The Indian diagnostics market is cited at Rs. 1.11 lakh crore with a 14% CAGR, and home sample collection is expected to make up 25-30% of this share. This expands the company's healthcare footprint beyond its existing wellness, nutraceutical, and herbal products business.
Separating Chairman and MD roles is a positive governance signal and may improve investor confidence. The diagnostics foray targets a fast-growing segment and could open a new revenue stream, though no financial commitments, timelines, or capital outlay have been disclosed yet, leaving execution risk open for shareholders to watch.